I3h in Media2018-07-15T02:18:28+00:00

I3h in Media

IMI: Celebrating 10 Years of Medical Innovations 
June 27th, 2018
Michel Goldman explains the Innovative Medicines Initiative, a unique European public-private partnership for healthcare innovation, on the occasion of the 10th anniversary celebration of IMI (interview for pharma.be)

EMBL Webinar: How to prepare and incentivise research scientists and healthcare professionals for collaborative innovation
April 27th, 2018
Michel Goldman and Hilde Stevens discussed the future of precision medicine and lessons learnt from our educational program that incentivises healthcare professionals to collaborate and develop their organizational skills
Link to the video

Collègue Belgique: Comment seront-nous soignés demain? – conférence par Michel Goldman
April 24th, 2018
Michel Goldman, founder and co-director of the I3h Institute, held a lecture on the future of medicine at the Belgian Academy of Medicine.
Link to the video (only French version available).

Only French version available.

DAILY SCIENCE: Les structures mélodiques et supramoléculaires rythment les journées de Jean Marie Lehn
March 9th, 2018
Pionnier dans le domaine de la chimie supramoléculaire et Prix Nobel de Chimie en 1987 pour sa contribution majeure à la connaissance des bases chimiques de la reconnaissance moléculaire (conjointement aux Pr Donald J. Cram et Charles J. Pedersen), le Pr Jean-Marie Lehn est également passionné de musique. Rencontre à Bruxelles, en marge de sa leçon inaugurale au « Baillet Latour Interdisciplinary Program in Translational Medicine ».
Link to the article.

L’ECHO: L’ULB veut pousser les futurs-médecins à tenter l’aventure biotech
January 25th, 2018
Cofondateur du pôle de compétitivité Biowin, Michel Goldman s’attache à bâtir des ponts entre les mondes académique et industriel.
Link to the article

POLITICO ProMorning Health Care: Sparking innovation
January 5th, 2018
Michel Goldman has met with Shirley Wang from POLITICO in order to discuss EU’s plans to promote research and innovation.“Obviously we need to invest more, but money is not enough,” Goldman told Morning Health Care. “I think money should be used in a way that fosters collaboration and facilitates competition, because we need both.”
Link to the article

Biotech Finances– No. 773
June 19th, 2017 
Comment faire gagner l’intelligence collective française et européenne!
“Impliquer les patients le plus tôt possible pour définir l’efficacité de la molécule”, Prof. .Michel Goldman explained in an interview with Biotech Finance. “Il faut surmonter le souci de profit immédiat pour explorer des voies de collaboration intéressantes à long terme pour la société et l’écosystème de la santé.”

Insideview: Frontiers
Nature Epub. 2016 Mar 17.
“Researchers and healthcare professionals need to become more comfortable working in interdisciplinary teams”, according to Prof. Michel Goldman.